Community Pharmacist’ attitudes towards counterfeit medicines in Yogyakarta, Indonesia

Open Access

Issue		BIO Web Conf. Volume 75, 2023 The 5^th International Conference on Bioinformatics, Biotechnology, and Biomedical Engineering (BioMIC 2023)


Article Number		05006
Number of page(s)		6
Section		Big Data for Public Health Policy
DOI		https://doi.org/10.1051/bioconf/20237505006
Published online		15 November 2023

CAd. Matos, CT. Ituassu, CAV. Rossi. Consumer attitudes toward counterfeits: a review and extension. Journal of Consumer Marketing. (24), 3647, (2007). [Google Scholar]
Guidelines for the development of measures to combat counterfeit drugs. In. Geneva: World Health Organization; 1999. [Google Scholar]
DE. Baker, Medication Counterfeiting. Hospital Pharmacy. (8), 683-684, (2014). [CrossRef] [PubMed] [Google Scholar]
BJ. Venhuis, PH. Keizers, R. Klausmann, I. Hegger. Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe. Drug Test Anal. (3-4):398-401, (2016). [CrossRef] [PubMed] [Google Scholar]
PN. Newto, MD. Green, FM. Fernández, NP. Day, White NJ. Counterfeit anti-infective drugs. Lancet Infect Dis. (9):602-613 (2006). [CrossRef] [PubMed] [Google Scholar]
L. Sholy, P. Gard, S. Williams, A. MacAdam. Pharmacist awareness and views towards counterfeit medicine in Lebanon. Int J Pharm Pract. (3):273-280, (2018). [CrossRef] [PubMed] [Google Scholar]
TK. Mackey, BA. Liang. The global counterfeit drug trade: patient safety and public health risks. J Pharm Sci. (11):4571-4579, (2011). [CrossRef] [PubMed] [Google Scholar]
EA. Blackstone, JP. Fuhr, Jr., S. Pociask. The health and economic effects of counterfeit drugs. Am Health Drug Benefits. (4):216-224, (2014). [Google Scholar]
A. Hasnida, MO. Kok, E. Pisani. Challenges in maintaining medicine quality while aiming for universal health coverage: a qualitative analysis from Indonesia. BMJ Global Health. (6), (2021) [Google Scholar]
S. Putra. Kronologi Pengungkapan Kasus Vaksin Palsu di Bekasi dan Tengerang. (2016). [Google Scholar]
Peraturan Menteri Kesehatan Republik Indonesia Nomor 284/MENKES/PER/III/2007 Tentang Apotek Rakyat (2007). [Google Scholar]
Peraturan Menteri Kesehatan Republik Indonesia Nomor 53 Tahun 2016 Tentang Pencabutan Peraturan Menteri Kesehatan Nomor 284/MENKES/PER/III/2007 Tentang Apotek Rakyat, (2016). [Google Scholar]
Association IP. Jadi Biang Kerok Obat Palsu, Permenkes Apotek Rakyat Akan Dicabut. (2016). [Google Scholar]
Mdege ND, Chevo T, Toner P. Perceptions of current and potential public health involvement of pharmacists in developing nations: The case of Zimbabwe. Res Social Adm Pharm. 2016; 12(6):876-884. [CrossRef] [PubMed] [Google Scholar]
NN. Gowri Rajapandian, A. Maheswaran and P. Chanchal. Dangerous World Of Counterfeit Drugs – Pharmacist’s Role And Its Prevention. International Journal of Pharmaceutical Science and Research (IJPSR). 1709-1713, (2013). [Google Scholar]
S. Shahverdi, M. Hajimiri, F. Pourmalek, H. Torkamandi, K. Gholami, S. Hanafi, NA. Shahmirzadi, M. Javadi. Iranian pharmacists’ knowledge, attitude, and practice regarding counterfeit drugs. Iran J Pharm Res. (3), 963-968, (2012). [Google Scholar]
LB. Sholy, PR. Gard, S. Williams, A. MacAdam, CE. Saliba CE. Public and pharmacist perceptions towards counterfeit medicine in Lebanon using focus groups. International Journal Of Community Medicine And Public Health. (2), 489-499, (2018). [CrossRef] [Google Scholar]
C. Brata, C. Fisher, B. Marjadi, CR. Schneider, Clifford RM. Factors influencing the current practice of self-medication consultations in Eastern Indonesian community pharmacies: a qualitative study. BMC Health Serv Res. (16), 179, (2016). [CrossRef] [Google Scholar]
WG. Chambliss, WA. Carroll, D. Kennedy, D. Levine, MA Mone, LD Ried, M Shepherd, M. Yelvigi. Role of the pharmacist in preventing distribution of counterfeit medications. J Am Pharm Assoc (2003). (2):195-199, (2012). [CrossRef] [PubMed] [Google Scholar]
A. Bashir, S. Galal S, A. Ramadan, A. Wahdan, L. El-Khordagui. Community pharmacists’ perceptions, awareness and practices regarding counterfeit medicines: a cross-sectional survey in Alexandria, Egypt. East Mediterr Health J. (5):556564, (2020). [Google Scholar]
E. Abdunasir, T. Sosengo, F. Amare, M. Yimam, B. Hagos. Assessment of awareness and attitude towards counterfeit medicines among pharmacy professionals working in community drug retail outlets in Harar town, Ethiopia. (2021). [Google Scholar]
YA. Taleb, MR. Pharmacists’ Awareness of Drug Counterfeiting in Jordan. Journal of The Royal Medical Services. (2):57-70, (2013). [CrossRef] [Google Scholar]
V U Odili SO, E U Eke, H A Okeri. Identification of Counterfeit Drugs by Community Pharmacists in Lagos State. Tropical Journal of Pharmaceutical Research. (5), (2006). [Google Scholar]
OP. Adigwe, G. Onavbavba, DO. Wilson. Challenges Associated with Addressing Counterfeit Medicines in Nigeria: An Exploration of Pharmacists’ Knowledge, Practices, and Perceptions. Integr Pharm Res Pract. (11):177-186, (2022). [PubMed] [Google Scholar]
PN. Newton, MD. Green, FM. Fernández. Impact of poor-quality medicines in the ’developing’ world. Trends Pharmacol Sci. (3):99-101, (2010). [CrossRef] [PubMed] [Google Scholar]
Undang-undang (UU) tentang Kesehatan, (2009). [Google Scholar]
Eni K. Vonis Rendah dari Hakim Membuat Pemalsu Obat tidak Jera. Media Indonesia, (2019). [Google Scholar]
AKHB. Lumbantobing, U. Utomo. Pertanggungjawaban Pidana Pelaku Yang Sengaja Menjual Obat-Obatan Yang Tidak Memenuhi Standar Mutu (Studi Putusan No: 1335/Pid.Sus/2018/Pn Medan). PATIK:Jurnal Hukum. (9), 203-214, (2020). [Google Scholar]
A silent epidemic: protecting the safety and security of drugs. Pharmaceutical Outsourcing; (2011). [Google Scholar]
Counterfeit Pharmaceutical Inter-Agency Working Group report to the Vice President of the United States and to Congress., (2011). [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.